{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:06:43Z","timestamp":1790017603711,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/leu.2017.75","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T02:40:29Z","timestamp":1488768029000},"page":"2057-2064","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL"],"prefix":"10.1038","volume":"31","author":[{"given":"Z","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B J","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Berezovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S H","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Sanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A S","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A T","family":"Look","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"key":"BFleu201775_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1101\/gr.157602.113","volume":"23","author":"DA Wheeler","year":"2013","unstructured":"Wheeler DA, Wang L . From human genome to cancer genome: the first decade. Genome Res 2013; 23: 1054\u20131062.","journal-title":"Genome Res"},{"key":"BFleu201775_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrg.2015.17","volume":"17","author":"E Khurana","year":"2016","unstructured":"Khurana E, Fu Y, Chakravarty D, Demichelis F, Rubin MA, Gerstein M . Role of non-coding sequence variants in cancer. Nat Rev Genet 2016; 17: 93\u2013108.","journal-title":"Nat Rev Genet"},{"key":"BFleu201775_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A et al. TERT promoter mutations in familial and sporadic melanoma. Science 2013; 339: 959\u2013961.","journal-title":"Science"},{"key":"BFleu201775_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA . Highly recurrent TERT promoter mutations in human melanoma. Science 2013; 339: 957\u2013959.","journal-title":"Science"},{"key":"BFleu201775_CR5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1126\/science.1259037","volume":"346","author":"MR Mansour","year":"2014","unstructured":"Mansour MR, Abraham BJ, Anders L, Berezovskaya A, Gutierrez A, Durbin AD et al. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science 2014; 346: 1373\u20131377.","journal-title":"Science"},{"key":"BFleu201775_CR6","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.1038\/ncomms7094","volume":"6","author":"JM Navarro","year":"2015","unstructured":"Navarro JM, Touzart A, Pradel LC, Loosveld M, Koubi M, Fenouil R et al. Site- and allele-specific polycomb dysregulation in T-cell leukaemia. Nat Commun 2015; 6: 6094.","journal-title":"Nat Commun"},{"key":"BFleu201775_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrc3418","volume":"13","author":"JM Matthews","year":"2013","unstructured":"Matthews JM, Lester K, Joseph S, Curtis DJ . LIM-domain-only proteins in cancer. Nat Rev Cancer 2013; 13: 111\u2013122.","journal-title":"Nat Rev Cancer"},{"key":"BFleu201775_CR8","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1101\/gad.12.17.2651","volume":"12","author":"TH Rabbitts","year":"1998","unstructured":"Rabbitts TH . LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev 1998; 12: 2651\u20132657.","journal-title":"Genes Dev"},{"key":"BFleu201775_CR9","first-page":"1103","volume":"5","author":"T Boehm","year":"1990","unstructured":"Boehm T, Foroni L, Kennedy M, Rabbitts TH . The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerisation motif. Oncogene 1990; 5: 1103\u20131105.","journal-title":"Oncogene"},{"key":"BFleu201775_CR10","doi-asserted-by":"publisher","first-page":"150062","DOI":"10.1098\/rsob.150062","volume":"5","author":"J Chambers","year":"2015","unstructured":"Chambers J, Rabbitts TH . LMO2 at 25 years: a paradigm of chromosomal translocation proteins. Open Biol 2015; 5: 150062.","journal-title":"Open Biol"},{"key":"BFleu201775_CR11","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1128\/MCB.19.7.5025","volume":"19","author":"DS Chervinsky","year":"1999","unstructured":"Chervinsky DS, Zhao XF, Lam DH, Ellsworth M, Gross KW, Aplan PD . Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice. Mol Cell Biol 1999; 19: 5025\u20135035.","journal-title":"Mol Cell Biol"},{"key":"BFleu201775_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ccr.2012.06.007","volume":"22","author":"T Sanda","year":"2012","unstructured":"Sanda T, Lawton LN, Barrasa MI, Fan ZP, Kohlhammer H, Gutierrez A et al. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell 2012; 22: 209\u2013221.","journal-title":"Cancer Cell"},{"key":"BFleu201775_CR13","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1182\/blood-2003-07-2577","volume":"103","author":"AA Ferrando","year":"2004","unstructured":"Ferrando AA, Herblot S, Palomero T, Hansen M, Hoang T, Fox EA et al. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Blood 2004; 103: 1909\u20131911.","journal-title":"Blood"},{"key":"BFleu201775_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/77819","volume":"1","author":"S Herblot","year":"2000","unstructured":"Herblot S, Steff AM, Hugo P, Aplan PD, Hoang T . SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression. Nat Immunol 2000; 1: 138\u2013144.","journal-title":"Nat Immunol"},{"key":"BFleu201775_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/j.1460-2075.1988.tb02825.x","volume":"7","author":"T Boehm","year":"1988","unstructured":"Boehm T, Baer R, Lavenir I, Forster A, Waters JJ, Nacheva E et al. The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J 1988; 7: 385\u2013394.","journal-title":"EMBO J"},{"key":"BFleu201775_CR16","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1002\/j.1460-2075.1988.tb03040.x","volume":"7","author":"T Boehm","year":"1988","unstructured":"Boehm T, Buluwela L, Williams D, White L, Rabbitts TH . A cluster of chromosome 11p13 translocations found via distinct D-D and D-D-J rearrangements of the human T cell receptor delta chain gene. EMBO J 1988; 7: 2011\u20132017.","journal-title":"EMBO J"},{"key":"BFleu201775_CR17","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1128\/MCB.9.5.2124","volume":"9","author":"EA McGuire","year":"1989","unstructured":"McGuire EA, Hockett RD, Pollock KM, Bartholdi MF, O'Brien SJ, Korsmeyer SJ . The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol 1989; 9: 2124\u20132132.","journal-title":"Mol Cell Biol"},{"key":"BFleu201775_CR18","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1182\/blood-2003-11-3944","volume":"104","author":"V Asnafi","year":"2004","unstructured":"Asnafi V, Beldjord K, Libura M, Villarese P, Millien C, Ballerini P et al. Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. Blood 2004; 104: 4173\u20134180.","journal-title":"Blood"},{"key":"BFleu201775_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","volume":"1","author":"AA Ferrando","year":"2002","unstructured":"Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75\u201387.","journal-title":"Cancer Cell"},{"key":"BFleu201775_CR20","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/leu.2013.2","volume":"27","author":"SH Oram","year":"2013","unstructured":"Oram SH, Thoms J, Sive JI, Calero-Nieto FJ, Kinston SJ, Schutte J et al. Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia. Leukemia 2013; 27: 1348\u20131357.","journal-title":"Leukemia"},{"key":"BFleu201775_CR21","doi-asserted-by":"publisher","first-page":"D117","DOI":"10.1093\/nar\/gku1045","volume":"43","author":"MA Hume","year":"2015","unstructured":"Hume MA, Barrera LA, Gisselbrecht SS, Bulyk ML . UniPROBE, update 2015: new tools and content for the online database of protein-binding microarray data on protein-DNA interactions. Nucleic Acids Res 2015; 43: D117\u2013D122.","journal-title":"Nucleic Acids Res"},{"key":"BFleu201775_CR22","doi-asserted-by":"publisher","first-page":"D77","DOI":"10.1093\/nar\/gkn660","volume":"37","author":"DE Newburger","year":"2009","unstructured":"Newburger DE, Bulyk ML . UniPROBE: an online database of protein binding microarray data on protein-DNA interactions. Nucleic Acids Res 2009; 37 : D77\u2013D82.","journal-title":"Nucleic Acids Res"},{"key":"BFleu201775_CR23","doi-asserted-by":"publisher","first-page":"D116","DOI":"10.1093\/nar\/gkv1249","volume":"44","author":"Kulakovskiy IV","year":"2016","unstructured":"Kulakovskiy IV, Vorontsov IE, Yevshin IS, Soboleva AV, Kasianov AS, Ashoor H et al. HOCOMOCO: expansion and enhancement of the collection of transcription factor binding sites models. Nucleic Acids Res 2016; 44: D116\u2013D125.","journal-title":"Nucleic Acids Res"},{"key":"BFleu201775_CR24","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1126\/science.aad9024","volume":"351","author":"D Hnisz","year":"2016","unstructured":"Hnisz D, Weintraub AS, Day DS, Valton AL, Bak RO, Li CH et al. Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science 2016; 351: 1454\u20131458.","journal-title":"Science"},{"key":"BFleu201775_CR25","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/leu.2013.377","volume":"28","author":"NM Anderson","year":"2014","unstructured":"Anderson NM, Harrold I, Mansour MR, Sanda T, McKeown M, Nagykary N et al. BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines. Leukemia 2014; 28: 1145\u20131148.","journal-title":"Leukemia"},{"key":"BFleu201775_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV et al. Signatures of mutational processes in human cancer. Nature 2013; 500: 415\u2013421.","journal-title":"Nature"},{"key":"BFleu201775_CR27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/ng.2701","volume":"45","author":"MB Burns","year":"2013","unstructured":"Burns MB, Temiz NA, Harris RS . Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet 2013; 45: 977\u2013983.","journal-title":"Nat Genet"},{"key":"BFleu201775_CR28","doi-asserted-by":"publisher","first-page":"e40321","DOI":"10.1371\/journal.pone.0040321","volume":"7","author":"J Seita","year":"2012","unstructured":"Seita J, Sahoo D, Rossi DJ, Bhattacharya D, Serwold T, Inlay MA et al. Gene Expression Commons: an open platform for absolute gene expression profiling. PLoS One 2012; 7: e40321.","journal-title":"PLoS One"},{"key":"BFleu201775_CR29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/2159-8290.CD-15-0344","volume":"5","author":"C Swanton","year":"2015","unstructured":"Swanton C, McGranahan N, Starrett GJ, Harris RS . APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity. Cancer Discov 2015; 5: 704\u2013712.","journal-title":"Cancer Discov"},{"key":"BFleu201775_CR30","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/j.1460-2075.1996.tb00439.x","volume":"15","author":"RC Larson","year":"1996","unstructured":"Larson RC, Lavenir I, Larson TA, Baer R, Warren AJ, Wadman I et al. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J 1996; 15: 1021\u20131027.","journal-title":"EMBO J"},{"key":"BFleu201775_CR31","doi-asserted-by":"publisher","first-page":"8617","DOI":"10.1073\/pnas.91.18.8617","volume":"91","author":"VE Valge-Archer","year":"1994","unstructured":"Valge-Archer VE, Osada H, Warren AJ, Forster A, Li J, Baer R et al. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc Natl Acad Sci USA 1994; 91: 8617\u20138621.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201775_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 2009; 10: 147\u2013156.","journal-title":"Lancet Oncol"},{"key":"BFleu201775_CR33","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1200\/JCO.2010.28.3390","volume":"28","author":"A Gutierrez","year":"2010","unstructured":"Gutierrez A, Dahlberg SE, Neuberg DS, Zhang J, Grebliunaite R, Sanda T et al. Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia. J Clin Oncol 2010; 28: 3816\u20133823.","journal-title":"J Clin Oncol"},{"key":"BFleu201775_CR34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature15540","volume":"528","author":"DA Oldridge","year":"2015","unstructured":"Oldridge DA, Wood AC, Weichert-Leahey N, Crimmins I, Sussman R, Winter C et al. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature 2015; 528: 418\u2013421.","journal-title":"Nature"},{"key":"BFleu201775_CR35","doi-asserted-by":"crossref","unstructured":"Palii CG, Pasha R, Brand M . Lentiviral-mediated knockdown during ex vivo erythropoiesis of human hematopoietic stem cells. J Vis Exp 2011; doi: 10.3791\/2813.","DOI":"10.3791\/2813"},{"key":"BFleu201775_CR36","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrg3729","volume":"15","author":"T Helleday","year":"2014","unstructured":"Helleday T, Eshtad S, Nik-Zainal S . Mechanisms underlying mutational signatures in human cancers. Nat Rev Genet 2014; 15: 585\u2013598.","journal-title":"Nat Rev Genet"},{"key":"BFleu201775_CR37","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","volume":"45","author":"SA Roberts","year":"2013","unstructured":"Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet 2013; 45: 970\u2013976.","journal-title":"Nat Genet"},{"key":"BFleu201775_CR38","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.molmed.2015.02.007","volume":"21","author":"S Henderson","year":"2015","unstructured":"Henderson S, Fenton T . APOBEC3 genes: retroviral restriction factors to cancer drivers. Trends Mol Med 2015; 21: 274\u2013284.","journal-title":"Trends Mol Med"},{"key":"BFleu201775_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 2016; 534: 47\u201354.","journal-title":"Nature"},{"key":"BFleu201775_CR40","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrg1674","volume":"6","author":"TR Gregory","year":"2005","unstructured":"Gregory TR . Synergy between sequence and size in large-scale genomics. Nat Rev Genet 2005; 6: 699\u2013708.","journal-title":"Nat Rev Genet"},{"key":"BFleu201775_CR41","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nature13393","volume":"511","author":"N Kwiatkowski","year":"2014","unstructured":"Kwiatkowski N, Zhang T, Rahl PB, Abraham BJ, Reddy J, Ficarro SB et al. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature 2014; 511: 616\u2013620.","journal-title":"Nature"},{"key":"BFleu201775_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Loven","year":"2013","unstructured":"Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013; 153: 320\u2013334.","journal-title":"Cell"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu201775.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu201775","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/leu.2017.75","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/leu201775.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:11:25Z","timestamp":1684419085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,6]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFleu201775"],"URL":"https:\/\/doi.org\/10.1038\/leu.2017.75","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727375062.793531336","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,6]]},"assertion":[{"value":"14 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}